9:00 AM ET: The President receives the Presidential Daily Briefing 11:15 AM ET: The President pardons the National Thanksgiving Turkey in a ceremony on the South Lawn. The…
Read More
Senators Inquire About Federal Agencies’ Use of AI Technology
DHS recently updated information on the use of the technology for several months prior to the public disclosure. Senators Ron Wyden of Oregon and Mike Crapo of Idaho…
Read More
GSA Explores Large Reduction of Federal Office Space
The federal government could reduce real estate by up to 30 percent and save billions. The General Services Administration, the real estate manager of the federal government, is…
Read More
DOJ Files Antitrust Suit Against Poultry Processor
The department alleges the company charged farmers penalty fees for switching processors. The Department of Justice partnered with the U.S. Department of Agriculture (USDA) to file a lawsuit…
Read MoreWhen You Need Comforting
“The LORD is my rock and my fortress and my deliverer, my God, my rock, in whom I take refuge, my shield, and the horn of my salvation, my stronghold.“
Read MoreMonday, November 20
Today, the House Ways and Means Committee and its Social Security Subcommittee are holding a field hearing in Baton Rouge, Louisiana. Committee Chair Jason Smith of Missouri and…
Read MoreNovember 20th – Monday
When the cares of my heart are many, Your consolations cheer my soul. – Psalm 94:19 Today is the president’s 81st birthday. Joseph Robinette Biden, Junior, born in…
Read More
Indo-Pacific Leaders Sign Clean and Fair Economy Agreements
Concludes latest IPEF meeting with with signing, larger agreement to come. The most recent week-long meeting between Indo-Pacific leaders concluded on Friday with the signing of a Supply…
Read MoreMichael Cloud, U.S. Representative for Texas’ 27th Congressional District
Michael Cloud is U.S. Representative for Texas’ 27th Congressional District. He has served since 2018. We pray that God will guide him as he represents the people of Texas…
Read More
FDA Approves New Treatment for Rare Blood Clotting Disorder
Director Marks announced the therapy for the life-threatening disorder. The U.S. Food and Drug Administration recently approved Adzynma for patients with congenital thrombotic thrombocytopenic purpura (cTTP). The genetically…
Read More